Drug profile · INN
pemirolast potassium
ALAMAST
pemirolast potassium (ALAMAST) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pemirolast potassium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pemirolast potassium (ALAMAST) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN pemirolast potassium
Brand ALAMAST
Mechanism Unknown
Route OPHTHALMIC
Formulation SOLUTION/DROPS
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is pemirolast potassium?
pemirolast potassium (ALAMAST) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for pemirolast potassium?
ALAMAST is a marketed brand name for pemirolast potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemirolast potassium?
pemirolast potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.